Response by Lei et al to letter regarding article, "Modernized Classification of Cardiac Antiarrhythmic Drugs"

Response by Lei et al to letter regarding article, "Modernized Classification of Cardiac Antiarrhythmic Drugs"

Podrobná bibliografie
Hlavní autoři:	Lei, M, Wu, L, Terrar, D, Huang, C
Médium:	Journal article
Jazyk:	English
Vydáno:	American Heart Association 2019

Podobné jednotky

Letter to the editor regarding the article of Chen et al.
Autor: Mehmet Sami Islamoglu, a další
Vydáno: (2022-12-01)

Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
Autor: Joanne J. A. van Bavel, a další
Vydáno: (2018-02-01)

Arrhythmia Models for Drug Research: Classification of Antiarrhythmic Drugs
Autor: Keitaro Hashimoto
Vydáno: (2007-01-01)

Letter by Antoniades et al regarding article, "Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction".
Autor: Antoniades, C, a další
Vydáno: (2010)

Letter by Rider and Neubauer regarding article, "Cardiac remodeling in obesity".
Autor: Rider, O, a další
Vydáno: (2013)

Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
Autor: T. N. Lipnitsky, a další
Vydáno: (2007-12-01)

Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
Autor: T. N. Lipnitsky, a další
Vydáno: (2007-12-01)

Modernised classification of cardiac anti-arrhytmic drugs
Autor: Lei, M, a další
Vydáno: (2018)

Response by Peterzan et al to letter regarding article, “Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction”
Autor: Peterzan, MA, a další
Vydáno: (2020)

Letter to the Editor Regarding Vaping Article
Autor: Rabbi Yehuda Spitz
Vydáno: (2019-10-01)

Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs
Autor: Sutanto, H, a další
Vydáno: (2019)

A Letter to the Editor on the Article by Farnam et al
Autor: Anne Rutte, MSc, a další
Vydáno: (2015-06-01)

Interactions that matter: 10 Antiarrhythmic drugs
Autor: Aronson, J
Vydáno: (1987)

Letter regarding article by Becker et al, "Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase".
Autor: Antoniades, C, a další
Vydáno: (2005)

Letter to the Editor regarding Cunningham et al. 2020
Vydáno: (2021-04-01)

Effects of Antiarrhythmic Drugs on Apoptotic Pathways in H9c2 Cardiac Cells
Autor: Shojiro Isomoto, a další
Vydáno: (2006-01-01)

A review on plants and herbal components with antiarrhythmic activities and their interaction with current cardiac drugs
Autor: Ahmad Beik, a další
Vydáno: (2020-05-01)

An algorithm for the selection of antiarrhythmic drugs for clinical pharmacologist
Autor: A. A. Upnitskiy
Vydáno: (2014-12-01)

Antiarrhythmic Drug Dosing in Children—Review of the Literature
Autor: Nathalie Oeffl, a další
Vydáno: (2023-05-01)

Letter to the editor—Opinion on article by Rodriguez-Alvarez F et al.
Autor: Santiago Rodríguez Villafuerte, a další
Vydáno: (2025-01-01)

A Letter to the Editor on the Article by Farnam et al.—Author's Response
Autor: Farnam Farnaz, PhD, a další
Vydáno: (2015-09-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
Autor: IRAJ NAZERY , a další
Vydáno: (1986-12-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
Autor: IRAJ NAZERY, a další
Vydáno: (1986-05-01)

Letter to the Editor regarding article Health effects of voluntary exposure to cold water – a continuing subject of debate, by Espeland, et al
Autor: Richard A. Reinhart
Vydáno: (2023-12-01)

Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
Autor: V. L. Doshchitsin, a další
Vydáno: (2022-07-01)

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
Autor: B. A. Tatarsky, a další
Vydáno: (2021-08-01)

Antiarrhythmic Drug Use in Pregnancy: Considerations and Safety Profiles
Autor: Marco Valerio Mariani, a další
Vydáno: (2024-08-01)

Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
Autor: Sean P. Gaine, a další
Vydáno: (2023-04-01)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
Autor: Gheorghe-Andrei Dan, a další
Vydáno: (2018-12-01)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
Autor: Ibrahim El-Battrawy, a další
Vydáno: (2019-08-01)

Electrophysiological Effects of a New Antiarrhythmic Drug Aksaritmin
Autor: Ravshanbek D. Kurbanov, a další
Vydáno: (2019-06-01)

Impact of Antiarrhythmic Drugs on Complex Fractionated Atrial Electrograms
Autor: Koichiro Kumagai, MD, a další
Vydáno: (2011-01-01)

Initiation and outcomes with Class Ic antiarrhythmic drug therapy
Autor: Xu Gao, a další
Vydáno: (2018-03-01)

Letter to the Editor in regard to the “Effects of COVID-19 on in-hospital cardiac arrest: incidence, causes, and outcome” by Roedl et al.”
Autor: A. D. Krieg, a další
Vydáno: (2021-11-01)

Response to letter by Campbell et al. regarding the results of the COSTICK trial
Autor: Andrew Smyth, a další
Vydáno: (2023-07-01)

Reply letter to “response to article by Johnna Perdrizet et al.” by Gomez and colleagues
Autor: Johnna Perdrizet, a další
Vydáno: (2022-01-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
Autor: K. A. Skiba, a další
Vydáno: (2003-06-01)

A letter to the editor regarding the original article by Costa et al: Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria
Autor: Biggs, M
Vydáno: (2019)

Letter to the Editor regarding article “Electrocardiographic markers of increased risk of sudden cardiac death in patients with COVID‐19 pneumonia”
Autor: Fenglin Jiang
Vydáno: (2021-07-01)

Response by Shimura et al. to the letter regarding article “Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement”
Autor: Tetsuro Shimura, a další
Vydáno: (2021-08-01)